Oxaliplatin | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Oxaliplatin
Canada

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

pharmacompass-1-m-2025-11-24

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Oxaliplatin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 24 USDMF, 29 CEP/COS, 7 JDMF, 6 EU WC, 26 KDMF, 8 NDC API, 27 Listed Suppliers, $ API Reference Price

69 API Suppliers
24 USDMF
29 CEP/COS
7 JDMF
6 EU WC
26 KDMF
8 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

651 Drugs in Development

651 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

282 FDF Dossiers, 69 FDA Orange Book, 136 Europe, 5 Canada, 6 Australia, 22 South Africa, 44 Listed Dossiers

282 FDF Dossiers
69 FDA Orange Book
136 Europe
5 Canada
6 Australia
22 South Africa
44 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML), INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)

INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
INJECTABLE;INTRAVENOUS - 50MG/10ML (5MG/ML)

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Capital Farma, 2 DFE Pharma, 9 Kerry, 2 Microlex e.U, 1 Pluviaendo, 1 Sigachi Industries

1 SPI Pharma
2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Capital Farma
2 DFE Pharma
9 Kerry
2 Microlex e.U
1 Pluviaendo
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

9 Fillers, Diluents & Binders, 7 Granulation, 5 Direct Compression, 2 Solubilizers, 2 Co-Processed Excipients, 1 Parenteral

9 Fillers, Diluents & Binders
7 Granulation
5 Direct Compression
2 Solubilizers
2 Co-Processed Excipients
1 Parenteral

DIGITAL CONTENT

45 News #PharmaBuzz

45 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 44 Regulatory FDF Prices, 7 Annual Reports

16 US Medicaid Prescriptions
44 Regulatory FDF Prices
7 Annual Reports

MARKET PLACE

11 APIs, 18 FDF Dossiers

11 APIs
18 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 11 Others

5 EDQM
11 Others

$ API Ref.Price (USD/KG) : 34,039 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 1DR REDDY'S LABORATORIES LTD

02 1FRESENIUS KABI CANADA LTD

03 1PFIZER CANADA ULC

04 1SANDOZ CANADA INCORPORATED

05 1TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

5 All

01 5OXALIPLATIN

filter Dosage Form Reset all filters

5 All

01 5SOLUTION

filter Brand Name Reset all filters

5 All

01 1OXALIPLATIN

02 2OXALIPLATIN INJECTION

03 2OXALIPLATIN INJECTION, USP

List of Suppliers

Product Main Page

01

DR REDDY'S LABORATORIES LTD

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION, USP

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2458403

Regulatory Info : Prescription

Registration Country : Canada

Dr Reddy Company Banner

Product Web Link

Digital Content

02

FRESENIUS KABI CANADA LTD

Austria

CPhI India

Not Confirmed

FRESENIUS KABI CANADA LTD

Austria

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Austria

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION, USP

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2457423

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

PFIZER CANADA ULC

CPhI India

Not Confirmed

PFIZER CANADA ULC

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2444763

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SANDOZ CANADA INCORPORATED

CPhI India

Not Confirmed

SANDOZ CANADA INCORPORATED

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/30/40ML

Approval Date :

Application Number : 2436957

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

TEVA CANADA LIMITED

CPhI India

Not Confirmed

TEVA CANADA LIMITED

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

OXALIPLATIN

Brand Name : OXALIPLATIN INJECTION

Dosage Form : SOLUTION

Dosage Strength : 5MG/ML

Packaging : 10/20/40ML

Approval Date :

Application Number : 2435071

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!